4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-021994
Chief Executive Officer gave up 5,865 shares (to pay taxes)
- Chief Executive Officer acquired 13,344 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2025-06-30 | Option exercise | +13,344 | 79,337 | D: show line 1 in the form | ||
| Robinson Chandler Chief Executive Officer | 2025-06-30 | Shares withheld for taxes | −5,865 | $35.78 | $209,850 | 73,472 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2025-06-30 | Option exercise · Restricted Stock Units | −13,344 | 81,325 | D: show line 3 in the form |
Loading xslF345X05/rdgdoc.xml…